Multi4: €75k

Case

20/04/23

We are thrilled to announce that our client, Multi4 Medical AB, has been awarded grant funding from Women TechEU, Horizon Europe to accelerate the commercialization of its groundbreaking surgical instrument for the diagnosis and treatment of bladder cancer. Multi4 is the first company in the world to successfully develop automated technology for endoscopic cancer diagnosis and treatment, and its new and patented technology has the potential to be a game changer for millions of patients worldwide.

Dr. Miden Melle Hannah, CEO Multi4 comments: “Multi4 AB expresses appreciation for the expert assistance and guidance provided by GAEU Consulting in the development of application for the Women Leadership Program from the European Innovation Council. The team possesses a high level of proficiency in navigating the process, providing necessary feedback and demonstrating the expert level of knowledge. We think that working with GAEU is a great experience.”

Previous
Previous

Qlucore AB (publ): €2.5m

Next
Next

Inossia: €7.3m